Editor’s Note: This article was originally published on November 21, 2022. This article has absolutely nothing to do with trend following or the markets....
Gilead Sciences’ (GILD) new HIV prevention shot, lenacapavir, hit it out of the park in a late-stage trial, showing 100% effectiveness. 2,000 women participated...
In this edition of StockCharts TV‘s The Final Bar, Dave celebrates Nvidia’s rise to overtake Microsoft (MSFT) as the largest company by market cap, creating chaos...
In this edition of StockCharts TV‘s The Final Bar, Dave breaks down an upside follow-through day for the S&P 500 and Nasdaq, and highlights the continued...